Antithrombin III for critically ill patients

Volume: 2018, Issue: 12
Published: Feb 9, 2016
Abstract
Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown. This review was published in 2008 and updated in 2015.To examine:1. The effect of AT III on mortality in critically ill...
Paper Details
Title
Antithrombin III for critically ill patients
Published Date
Feb 9, 2016
Volume
2018
Issue
12
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.